The diagnosis and prognostication of glioblastoma (GBM) remain to be solely dependent on histopathological findings and few molecular markers, despite the clinical heterogeneity in this entity. To address this…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...